FDA Panel Backs Approval Of Drug For HIV Prevention

A U.S. Food and Drug Administration advisory committee on Thursday recommended that the FDA approve Gilead Sciences Inc.'s Truvada, an antiviral drug that could prevent HIV, with some lauding it as...

Already a subscriber? Click here to view full article